Feature

Cancer the most common diagnosis in palliative care patients


 

More than a quarter of the patients in palliative care have a primary diagnosis of cancer, according to the Center to Advance Palliative Care.

A survey of 351 palliative care programs showed that 27% of their patients had been diagnosed with cancer in 2016, more than twice as many patients who had a cardiac (13%) or pulmonary (12%) diagnosis. The next most common primary diagnosis category in 2016 was neurologic at 8%, with a tie at 6% between diagnoses classified as infectious or complex chronic, followed by patients with dementia at 5%, Maggie Rogers and Tamara Dumanovsky, PhD, of the CAPC reported.

Most common primary diagnosis categories
By specialty, more than half of referrals to palliative care came from hospital medicine (53.5%), while 12% were referred by internal/family medicine, another 12% by pulmonary/critical care medicine, and 7% by oncology, Ms. Rogers and Dr. Dumanovsky said in their analysis of data from the CAPC’s National Palliative Care Registry.

A medical/surgical unit was the referring site for 43% of palliative care referrals in 2016, with 26% of patients coming from an intensive care unit, 13% from a step-down unit, and 8% from an oncology unit, they noted.

Recommended Reading

Perceived financial hardship among patients with advanced cancer
MDedge Hematology and Oncology
Pancreatitis associated with newer classes of antineoplastic therapies
MDedge Hematology and Oncology
Idarucizumab reversed dabigatran completely and rapidly in study
MDedge Hematology and Oncology
Physician liability in opioid deaths
MDedge Hematology and Oncology
Ibrutinib becomes first FDA-approved treatment for chronic GVHD
MDedge Hematology and Oncology
Alopecia may be permanent in one in four pediatric HSCT patients
MDedge Hematology and Oncology
LIFSCREEN data support broader cancer screening in Li-Fraumeni syndrome
MDedge Hematology and Oncology
Solid organ transplantation contributes significantly to incidence of NHL among children and adolescents
MDedge Hematology and Oncology
ALLOZITHRO trial: HSCT patients fared worse with azithromycin
MDedge Hematology and Oncology
VHA warns California clinicians on assisted suicide
MDedge Hematology and Oncology